株式を売却した主な投資家にかかわらず,ResMedは,株当たりの収益の92.7%の飛躍を報告した. Despite major investors selling off shares, ResMed reported a 92.7% jump in earnings per share.

カリフォルニア州公務員退職金制度 (CalPERS) と他の機関投資家は医療機器会社ResMed Inc. (RMD) の株式を売却し,その株式を削減しました. California Public Employees Retirement System (CalPERS) and other institutional investors have sold shares of medical device company ResMed Inc. (RMD), reducing their stakes. これらの売上にもかかわらず,ResMedは,株当たり利益が92.7%増加し,推定値を超えて2.43ドルに達した強力な利益を報告した. Despite these sales, ResMed reported strong earnings, with a 92.7% increase in earnings per share to $2.43, surpassing estimates. 株式会社の市場資本は326.2億ドルで,アナリストからは"適度な買い"の評価を得ている. The company has a market capitalization of $32.62 billion and a "Moderate Buy" rating from analysts.